XML 51 R39.htm IDEA: XBRL DOCUMENT
v3.21.2

Derivative Instruments, Hedging Activities and Fair Value (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Schedule of fair value of outstanding derivative contracts | The fair value of outstanding derivative contracts recorded as assets and liabilities on the Company's Condensed Consolidated Balance Sheets was as follows:
(In thousands) |  | Balance Sheet Location |  | Fair Value of Derivatives Designated as Hedging Instruments |  | Fair Value of Derivatives Not Designated as Hedging Instruments |  | Total Fair Value
September 30, 2021 |  |  |  |  |  |  |  |
Asset derivatives (Level 2): |  |  |  |  |  |  |  |
Foreign currency exchange forward contracts |  | Other current assets |  | $ | 930 |  |  | $ | 8,718 |  |  | $ | 9,648 |
Total |  |  |  | $ | 930 |  |  | $ | 8,718 |  |  | $ | 9,648 |
(In thousands) |  | Balance Sheet Location |  | Fair Value of Derivatives Designated as Hedging Instruments |  | Fair Value of Derivatives Not Designated as Hedging Instruments |  | Total Fair Value
Liability derivatives (Level 2):
Foreign currency exchange forward contracts |  | Other current liabilities |  | $ | 851 |  |  | $ | 866 |  |  | $ | 1,717 |
Interest rate swaps |  | Other current liabilities |  | 4,068 |  |  | — |  |  | 4,068 |
Interest rate swaps |  | Other liabilities |  | 1,053 |  |  | — |  |  | 1,053 |
Total |  |  |  | $ | 5,972 |  |  | $ | 866 |  |  | $ | 6,838 |
December 31, 2020 |  |  |  |  |  |  |  |
Asset derivatives (Level 2): |  |  |  |  |  |  |  |
Foreign currency exchange forward contracts |  | Other current assets |  | $ | 900 |  |  | $ | 2,777 |  |  | $ | 3,677 |
Total |  |  |  | $ | 900 |  |  | $ | 2,777 |  |  | $ | 3,677 |
Liability derivatives (Level 2):
Foreign currency exchange forward contracts |  | Other current liabilities |  | $ | 950 |  |  | $ | 4,098 |  |  | $ | 5,048 |
Interest rate swaps |  | Other current liabilities |  | 3,959 |  |  | — |  |  | 3,959 |
Interest rate swaps |  | Other liabilities |  | 3,718 |  |  | — |  |  | 3,718 |
Total |  |  |  | $ | 8,627 |  |  | $ | 4,098 |  |  | $ | 12,725 |
Schedule of effect of derivative instruments | Derivatives Designated as Hedging Instruments
|  | Amount Recognized in OCI on Derivatives |  | Location of Amount Reclassified from AOCI into Income |  | Amount Reclassified from AOCI into Income - Effective Portion or Equity
|  | Three Months Ended |  |  | Three Months Ended
|  | September 30 |  |  | September 30
(In thousands) |  | 2021 |  | 2020 |  |  | 2021 |  | 2020
Foreign currency exchange forward contracts |  | $ | 611 |  |  | $ | (1,244) |  |  | Product revenues |  | $ | (418) |  |  | $ | 174 |
Interest rate swaps |  | (27) |  |  | (95) |  |  | Interest expense |  | 872 |  |  | 739 |
CCIRs (a) |  | — |  |  | (24) |  |  | Interest expense |  | — |  |  | 312 |
|  | $ | 584 |  |  | $ | (1,363) |  |  |  |  | $ | 454 |  |  | $ | 1,225 |
|  | Amount Recognized in OCI on Derivatives |  | Location of Amount Reclassified from AOCI into Income |  | Amount Reclassified from AOCI into Income - Effective Portion or Equity
|  | Nine Months Ended |  |  | Nine Months Ended
|  | September 30 |  |  | September 30
(In thousands) |  | 2021 |  | 2020 |  |  | 2021 |  | 2020
Foreign currency exchange forward contracts |  | $ | 170 |  |  | $ | 834 |  |  | Product revenues |  | $ | (465) |  |  | $ | (1,562) |
Interest rate swaps |  | (41) |  |  | (3,835) |  |  | Interest expense |  | 2,599 |  |  | 1,849 |
CCIRs (a) |  | — |  |  | 39 |  |  | Interest expense |  | — |  |  | 912 |
|  | $ | 129 |  |  | $ | (2,962) |  |  |  |  | $ | 2,134 |  |  | $ | 1,199 |
(a) Amounts represent changes in foreign currency translation related to balances in AOCI. The location and amount of gain (loss) recognized on the Company's Condensed Consolidated Statements of Operations was as follows:
|  | Three Months Ended
|  | September 30
|  | 2021 |  |  |  | 2020
(in thousands) |  | Product Revenues |  |  |  | Interest Expense |  |  |  | Product Revenues |  |  |  | Interest Expense |  |
Total amounts of line items presented in the Condensed Consolidated Statement of Operations in which the effects of cash flow hedges are recorded |  | $ | 105,677 |  |  |  |  | $ | (16,004) |  |  |  |  | $ | 124,892 |  |  |  |  | $ | (15,794) |  |  |
Interest rate swaps: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gain or (loss) reclassified from AOCI into income |  | — |  |  |  |  | (872) |  |  |  |  | — |  |  |  |  | (739) |  |  |
Foreign exchange contracts: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gain or (loss) reclassified from AOCI into income |  | 418 |  |  |  |  | — |  |  |  |  | (174) |  |  |  |  | — |  |  |
Amount excluded from effectiveness testing recognized in earnings based on changes in fair value |  | 24 |  |  |  |  | — |  |  |  |  | 12 |  |  |  |  | — |  |  |
Amount excluded from the effectiveness testing recognized in earnings based on an amortization approach |  | (1) |  |  |  |  | — |  |  |  |  | 3 |  |  |  |  | — |  |  |
CCIRs: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loss reclassified from AOCI into income |  | — |  |  |  |  | — |  |  |  |  | — |  |  |  |  | (312) |  |  |
|  | Nine Months Ended
|  | September 30
|  | 2021 |  | 2020
(in thousands) |  | Product Revenues |  |  |  | Interest Expense |  | Product Revenues |  |  |  | Interest Expense |  |
Total amounts of line items presented in the Condensed Consolidated Statement of Operations in which the effects of cash flow hedges are recorded |  | $ | 343,171 |  |  |  |  | $ | (48,854) |  |  | $ | 333,782 |  |  |  |  | $ | (43,396) |  |  |
Interest rate swaps: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gain or (loss) reclassified from AOCI into income |  | — |  |  |  |  | (2,599) |  |  | — |  |  |  |  | (1,849) |  |  |
Foreign exchange contracts: |  |  |  |  |  |  |  |  |  |  |  |
Gain or (loss) reclassified from AOCI into income |  | 465 |  |  |  |  | — |  |  | 1,562 |  |  |  |  | — |  |  |
Amount excluded from effectiveness testing recognized in earnings based on changes in fair value |  | 62 |  |  |  |  | — |  |  | 208 |  |  |  |  | — |  |  |
Amount excluded from the effectiveness testing recognized in earnings based on an amortization approach |  | (1) |  |  |  |  | — |  |  | 24 |  |  |  |  | — |  |  |
CCIRs: |  |  |  |  |  |  |  |  |  |  |  |
Loss reclassified from AOCI into income |  | — |  |  |  |  | — |  |  | — |  |  |  |  | (912) |  |  |
Derivatives Not Designated as Hedging Instruments
|  | Location of Gain (Loss) Recognized in Income on Derivatives |  | Amount of Gain (Loss) Recognized in Income on Derivatives (b)
|  |  | Three Months Ended |  | Nine Months Ended
|  |  | September 30 |  | September 30
(In thousands) |  |  | 2021 |  | 2020 |  | 2021 |  | 2020
Foreign currency exchange forward contracts |  | Cost of services and products sold |  | $ | 4,105 |  |  | $ | (12,279) |  |  | $ | 8,109 |  |  | $ | (5,001) |
(b) These gains (losses) offset amounts recognized in cost of services and products sold principally as a result of intercompany or third party foreign currency exposures.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4E -URI http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -URI http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration